Course Library

Printable Courses PDF

Search by Keyword

Learning at Dana-Farber Online Courses

  • CINV: Ongoing Issues and Updated Solutions

    Course Experts: Iman Suliman, PharmD, BCACP and Kimberly Noonan, DNP, ANP-BC, AOCN

    Course Description: This course reviews the updates in classes of highly, moderate, and low emetogenic intravenous and oral anticancer agents and the appropriate corresponding management strategies for Chemotherapy Induced Nausea and Vomiting (CINV).

    CINV (Chemotherapy-Induced Nausea and Vomiting), Antiemetic, Emetogenic, Prophylaxis, Dexamethasone, Olanzapine, Lorazepam, Pathophysiology, Neurotransmitters, Serotonin, Dopamine, Histamine, Acetylcholine, Neurokinin, Cannabinoid, Emesis, NCCN (National Comprehensive Cancer Networ...

  • Cancer During Pregnancy: What Should Pharmacists Know?

    Course Experts: Fuwang Xu, PharmD

    Course Description: This course reviews the latest information on the safety profile of chemotherapy and supportive care medications during pregnancy, and outlines key concepts when considering chemotherapy in pregnant and breastfeeding patients.

  • Cardiotoxicity in Breast Cancer

    Course Experts: Anju Nohria, MD, MSc; Amal Arnaout, PharmD; and Iman Suliman, PharmD, BCACP

    Course Description: This course explains the intersection between breast cancer and cardiovascular disease. It outlines cardiotoxicities of breast cancer therapy and identifies the available treatment options in the setting of cardiotoxicity.

  • Chemotherapy-Induced Peripheral Neuropathy: A Review of the Guidelines

    Course Experts: Molly Bacon, PharmD

    Course Description: This course will define CIPN, identify risk factors and causative agents and discuss the literature supporting non-pharmacologic and pharmacologic preventative and treatment methods.

    Chemotherapy-Induced Peripheral Neuropathy (CIPN), Risk Factors, Causative Agents, Nonpharmacologic Treatments, Pharmacologic Treatments, ASCO Guidelines, Sensory Symptoms, Motor Symptoms, Autonomic Symptoms, Platinum-Based Agents, Taxanes, Protease Inhibitors, Thalidomide, Epothilones, Vinca Alkaloids, Oxaliplatin, Paclitaxel, Bortezomib, Duloxetine, Prevention and Treatmen...

  • Clinical Pearls for Methadone Use in Oncology and Palliative Care

    Course Experts: Annabelle Hood, PharmD; Molly Bacon, PharmD and Iman Suliman, PharmD, BCACP

    Course Description: This course identifies unique pharmacokinetic and pharmacodynamic properties of methadone in the palliative care setting and describes factors in determining cardiac monitoring of methadone.

    Methadone, Pharmacokinetics, Pharmacodynamics, Palliative Care, Oncology, Pain Management, Opioid Receptors, NMDA Receptor, Cardiac Monitoring, QT Prolongation, Adjuvant Therapy, Co-analgesic, Conversion Ratios, Bioavailability, Metabolites, CYP3A4, EKG Monitoring, Torsades de Pointes, Renal Impairment, Hepatic...

  • Colorectal Cancer: An Overview

    Course Experts: Nina Grenon, DNP, AOCN; Samantha Morrison-Ma, CNP, MSN, RN, ANP-C, WHNP-BC; and Leila Rostamnjad, PharmD, BCOP

    Course Description: This course provides an overview of colorectal cancer including colorectal cancer risk, diagnosis, pathology, treatment, and management of treatment-related adverse effects.

    Colorectal Cancer (CRC), Risk Factors, Staging, Pathophysiology, Screening, Molecular Profiling, Treatment Paradigms, Side Effects, Local Therapy, Systemic Therapy, Metastatic Disease, Adenocarcinoma, TNM Staging, Genetic Mutations, KRAS, BRAF, HER2, Microsatellite Instability (MSI), Targeted Therapies, Ch...

  • Drug Diversion, Detection and Prevention

    Course Experts: Iman Suliman, PharmD, BCACP

    Course Description: This course will review the fundamentals of drug diversion detection and prevention. Drug diversion is often underreported and can be difficult to detect in healthcare organizations; therefore, education is key.

    Drug Diversion, Healthcare, Opioids, Fentanyl, Overdose, Signs and Symptoms, Substance Use Disorder, Controlled Substances, Theft, Prescription Forgery, COVID-19 Impact, Healthcare Workers (HCWs), Detection, Prevention, Reporting, Stakeholders, System Limitations, Safeguards, CSDPP (Controlled Substances Diversion Prevention P...

  • Emergency Responses in a Pediatric Ambulatory Oncology Clinic

    Course Experts: Patrick McBride, PharmD, BCOP

    Course Description: This course summarizes appropriate management for pediatric infusion reactions and pediatric seizures. It compares the differences between pediatric and adult code cart contents and dosing references.

    Pediatric Oncology, Infusion Reactions, Seizures, Status Epilepticus, Code Cart, Febrile Neutropenia, Sepsis, Septic Shock, Broselow Tape, Anaphylaxis, Epinephrine, Antihistamine, Lorazepam, Fosphenytoin, Vasoactive Medications, Hypotension, Empiric Treatment, Antibiotics, Pharmacist Roles, Emergency Response

  • Exploring the Evolving Field of Chronic Graft-Versus-Host Disease: Management Strategies

    Course Experts: Melinda Cook, PharmD and Eno Inyang, PharmD, BCPS, BCOP

    Course Description: This course examines chronic GVHD pathophysiology, novel treatment options, evaluates prophylactic therapies for prevention, and analyzes treatments for both steroid-naïve and steroid-refractory cases.

    Chronic Graft-Versus-Host Disease (GVHD), Prophylactic Therapies, Steroid-Naive, Steroid Refractory, Hematopoietic Stem Cell Transplant, Autologous Transplant, Allogeneic Transplant, Acute GVHD, Chronic GVHD, Immunosuppression, Thrombocytopenia, Cytokines, Endothelial Damage, Fibrosis, Tacrolimus, Methotrexate, Cyclopho...

  • Fast Food or Fine Dining: Reviewing Bispecific Antibodies and Chimeric Antigen Receptor T-cells

    Course Experts: Shahrier Hossain, PharmD, BCOP; Ashka Patel, PharmD, BCOP; Charles Ni, PharmD, MPH, BCOP; Emily Tiao, PharmD, BCOP

    Course Description: This course covers the workings of CAR-T therapy and bispecific antibodies, assessing major trials, efficacy, safety, and managing side effects like cytokine release syndrome and neurotoxicity associated with these treatments.

  • Human Factors in the Ambulatory Oncology Setting

    Course Experts: Emily Messing, PharmD, BCPS

    Course Description: This course reviews human factorsand how human factors engineering can be used to improve patient safety in the oncology settings.

  • ITP An Update: New Routes, New Options and New Outcomes

    Course Experts: Shahrier Hossain, PharmD

    Course Description: This course compares different treatment options for chronic thrombocytopenia, recommends a thrombopoietin agonist based on patient-specific factors, and identifies the role of fostamatinib in therapy.

    Immune Thrombocytopenia (ITP), Thrombocytopenia, Fostamatinib, Splenectomy, Rituximab, TPO Receptor Agonists (TPO-RAs), Romiplostim, Eltrombopag, Avatrombopag, Pathophysiology, Autoantibodies, Megakaryocytes, Reticuloendothelial System, Hepatotoxicity, Cataract Formation, Bone Marrow Fibrosis, MDS Transformation, IVIG, Anti-D, Steroid Refractory